<ul><li>Toronto-based psychedelic therapy company Field Trip Health has completed its previously announced spin-out transaction which split the company into two, rebranding the Field Trip Discovery division to Reunion Neuroscience Inc. and the clinics' division to Field Trip Health & Wellness (FTHW).</ul>
Reunion Neuroscience will continue to trade on the Nasdaq Stock Market and Toronto Stock Exchange (TSX) under the ticker symbol “FTRP”, which is expected to change to “REUN” by August 17, 2022. Just last week, FTHW received conditional approval to list its common shares on the Toronto Stock Exchange (TSX) under the ticker symbol “FTHW”. The first day of trading is also expected to be on or about August 17, 2022.
Simultaneously, FTHW completed a non-brokered private placement of 35.6 million shares at a rate of CAD 0.50 (USD 0.4) per share, and a brokered private placement of 4.4 million subscription receipts at a rate of CAD 0.5 (USD 0.4) per receipt. The gross proceeds from the offerings amounted to CAD 20 million (USD 16 million).
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.